About
Allurion Technologies is a healthcare company dedicated to combating obesity through its innovative weight loss platform. Founded in 2009 and based in Natick, Massachusetts, the company is known for its flagship product, the Allurion Gastric Balloon. This swallowable, procedure-less intragastric balloon helps individuals lose weight without the need for surgery, endoscopy, or anesthesia. The Allurion Program combines the gastric balloon with the Allurion Virtual Care Suite, which includes AI-powered remote patient monitoring, a behavior change program, secure messaging, video telehealth, and connected devices like the Allurion Connected Scale and Health Tracker. This comprehensive approach allows clinicians to effectively manage weight loss therapy. Patients using the Allurion Program typically experience a weight loss of 10-15% of their total body weight within about 16 weeks. Allurion operates internationally, with a presence in countries such as Spain, France, and Turkey, and is publicly traded on the NYSE under the ticker symbol ALUR. The company's mission is to promote sustainable weight loss and improve the quality of life for patients worldwide.
Technologies
Keywords
Company Information
-
Employees 140
-
Founded 2009
-
Annual Revenue $28304000
-
Total Funding $198560678
Location
14 Huron Drive, Natick, Massachusetts, United States, 01760